Picard Medical Investors Face Conflicting Deadlines as Class Action Moves Toward Lead‑Plaintiff Fight
The case centers on claims that a social‑media hype scheme distorted PMI shares through insider selling.
Overview
- A securities class action has been filed against Picard Medical covering September 2 to October 31, 2025.
- Four law firms — Rosen, Schall, Levi & Korsinsky, and the Law Offices of Frank R. Cruz — are recruiting PMI investors to seek the lead‑plaintiff role.
- Competing notices list different motion deadlines, with Schall, Levi & Korsinsky, and Frank R. Cruz citing April 3, 2026, while Rosen cites April 13, 2026.
- The complaint alleges a coordinated stock‑promotion push that used social‑media misinformation and impersonated financial advisers to lift the share price.
- It also claims insiders or affiliates dumped shares through offshore or nominee accounts during the run‑up, and no class has been certified.